Back to top
more

Cytosorbents (CTSO)

(Real Time Quote from BATS)

$0.88 USD

0.88
41,698

-0.01 (-1.12%)

Updated Jun 11, 2024 11:58 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (90 out of 250)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

Cytosorbents Corporation [CTSO]

Reports for Purchase

Showing records 121 - 140 ( 185 total )

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 121

01/17/2017

Daily Note

Pages: 3

Expanded Fresenius Partnership to Bolster 2017; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: RAMAKANTH S

Price: 10.00

Research Provided by a Third Party

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 122

01/13/2017

Company Report

Pages: 7

Price: 24.95

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 123

12/27/2016

Company Report

Pages: 6

Price: 24.95

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 124

11/14/2016

Company Report

Pages: 10

Price: 24.95

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 125

11/08/2016

Company Report

Pages: 6

Fresenius Partnership Contributing; Terumo to Roll Out in 4Q16; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: RAMAKANTH S

Price: 25.00

Research Provided by a Third Party

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 126

10/11/2016

Daily Note

Pages: 4

REFRESH I Data in 1H17; Looking Ahead to REFRESH II; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: RAMAKANTH S

Price: 10.00

Research Provided by a Third Party

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 127

10/05/2016

Company Report

Pages: 5

Price: 24.95

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 128

08/16/2016

Company Report

Pages: 7

Price: 24.95

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 129

08/12/2016

Company Report

Pages: 7

Price: 24.95

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 130

08/11/2016

Company Report

Pages: 6

Fresenius Agreement Contributing; Expect Sales to Ramp Up; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: RAMAKANTH S

Price: 25.00

Research Provided by a Third Party

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 131

06/02/2016

Company Report

Pages: 5

Price: 24.95

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 132

05/11/2016

Company Report

Pages: 7

Price: 24.95

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 133

05/10/2016

Company Report

Pages: 7

Reports 1Q16 Results; Maintaining BUY Rating

Provider: Merriman Curhan Ford & Co.

Analyst: D SILVA A

Price: 25.00

Research Provided by a Third Party

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 134

05/10/2016

Company Report

Pages: 6

Fresenius to Rollout in May; REFRESH to Report in 3Q16; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: RAMAKANTH S

Price: 25.00

Research Provided by a Third Party

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 135

05/03/2016

Company Report

Pages: 7

Update On Recent Events

Provider: Merriman Curhan Ford & Co.

Analyst: D SILVA A

Price: 25.00

Research Provided by a Third Party

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 136

03/11/2016

Company Report

Pages: 6

Clinical Data Could Potentiate Commercial Expansion in 2016; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: RAMAKANTH S

Price: 25.00

Research Provided by a Third Party

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 137

03/10/2016

Company Report

Pages: 6

Price: 24.95

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 138

02/29/2016

Company Report

Pages: 5

CTSO Announces Positive Top Line Data From An Investigator Initiated Study

Provider: Merriman Curhan Ford & Co.

Analyst: D SILVA A

Price: 10.00

Research Provided by a Third Party

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 139

02/26/2016

Company Report

Pages: 5

Price: 24.95

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 140

02/11/2016

Industry Report

Pages: 25

Discouraging Trading Trends Beg the Question: What Will Happen to the Russell 3000?

Provider: Rodman & Renshaw, Co.

Price: 75.00

Research Provided by a Third Party